Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, et al.

N Engl J Med. 1991 Aug 1;325(5):303-10.

2.

Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III.

Cohn JN.

Drugs. 1994;47 Suppl 4:47-57; discussion 57-8. Review.

PMID:
7523062
3.

Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.

Elkayam U, Bitar F.

Am J Cardiol. 2005 Oct 10;96(7B):37i-43i. Epub 2005 Aug 9. Review.

PMID:
16226934
5.

Role of isosorbide dinitrate in management of chronic congestive heart failure.

Parmley WW.

Am Heart J. 1985 Jul;110(1 Pt 2):264-8. Review.

PMID:
3893081
6.
8.
9.

Lessons from recent randomized controlled trials for the management of congestive heart failure.

Riegger GA.

Am J Cardiol. 1993 Jun 24;71(17):38E-40E. Review.

PMID:
8328366
10.

The African American Heart Failure Trial: a clinical trial update.

Taylor AL.

Am J Cardiol. 2005 Oct 10;96(7B):44-8. Epub 2005 Aug 9. Review.

PMID:
16226935
11.

Studies of Left Ventricular Dysfunction (SOLVD)--new hope for heart failure.

[No authors listed]

S Afr Med J. 1991 Nov 2;Suppl:1-8. Review. No abstract available.

PMID:
1957226
12.

Congestive heart failure: what should be the initial therapy and why?

Chatterjee K.

Am J Cardiovasc Drugs. 2002;2(1):1-6. Review.

PMID:
14727993
13.

The impact of race on response to RAAS inhibition.

Wallace TW, Drazner MH.

Curr Heart Fail Rep. 2005 Aug;2(2):72-7. Review.

PMID:
16036054
14.

Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety.

Ferdinand KC.

Expert Rev Cardiovasc Ther. 2005 Nov;3(6):993-1001. Review.

PMID:
16292990
15.

Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.

Colvin-Adams M, Taylor AL.

Cleve Clin J Med. 2007 Mar;74(3):227-34. Review.

PMID:
17375804
16.

Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.

Ferdinand KC, Elkayam U, Mancini D, Ofili E, PiƱa I, Anand I, Feldman AM, McNamara D, Leggett C.

Am J Cardiol. 2014 Jul 1;114(1):151-9. doi: 10.1016/j.amjcard.2014.04.018. Epub 2014 Apr 18. Review.

17.

Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.

Mantle JA, Russell RO Jr, Moraski RE, Rackley CE.

Am J Cardiol. 1976 Feb;37(2):263-8. Review.

PMID:
1108634
18.

[Vasodilator therapy in cardiac failure].

Akatsuka N.

Nihon Rinsho. 1993 May;51(5):1276-80. Review. Japanese.

PMID:
8101237
19.

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.

Echols MR, Yancy CW.

Vasc Health Risk Manag. 2006;2(4):423-31. Review.

20.

Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions.

Cole RT, Kalogeropoulos AP, Georgiopoulou VV, Gheorghiade M, Quyyumi A, Yancy C, Butler J.

Circulation. 2011 May 31;123(21):2414-22. doi: 10.1161/CIRCULATIONAHA.110.012781. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk